CEMIVAMERAN

UNII:	3W7YFK5FNA
Type:	INGREDIENT SUBSTANCE
Formula:
Preferred Substance Name:	CEMIVAMERAN
GSRS Full Record:	3W7YFK5FNA i

3036385-75-5
BNT162b2 Omicron (KP.2)
Cemivameran
Cemivameran [WHO-DD]
RNA (recombinant 5′-[1,2-[(3′-O-methyl)m7G-(5′→5′)-ppp-Am]]-capped all uridine→N1-methylpseudouridine-substituted severe acute respiratory syndrome coronavirus 2 spike glycoprotein secretory signal peptide plus codon-optimized pre-fusion spike glycoprotein omicron KP.2 variant [982-proline,983-proline]-specifying plus 5′- and 3′-untranslated flanking region-containing poly(A)-tailed messenger RBP020.33), inner salt
cemivameran [INN]
messenger RNA (mRNA), 5'-capped, encoding a fulllength, codon-optimised pre-fusion stabilised conformation variant (K982P and V983P) of the SARSCoV-2 (severe acute respiratory syndrome coronavirus 2) spike (S) glycoprotein (Omicron KP.2 variant; GISAID: EPI_ISL_18912216), flanked by 5' and 3' untranslated regions and a 3' polyadenylation (polyA) tail; contains N1-methylpseudouridine instead of uridine (all-U>m1Ψ)

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

CEMIVAMERAN

Synonyms and Mappings

Resources